Medical Imaging (MEDD) 10-Q 13 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 01, 2014
Document And Entity Information	'	'
Entity Registrant Name	'MEDICAL IMAGING CORP.	'
Entity Central Index Key	'0001370804	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	23,821,481
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current Assets	'	'
Cash and Cash Equivalents	$150,088	$77,300
Accounts Receivable, net	385,262	295,614
Prepaid Expenses	10,633	5,364
Total Current Assets	545,983	378,278
Property and Equipment	'	'
Equipment	1,523,583	1,437,464
Less: Accumulated Depreciation	-317,192	-237,763
Total Property and Equipment, net	1,206,391	1,199,701
Intangibles	'	'
Hospital Contracts	524,585	794,707
Non-Compete Contract	133,245	133,245
Less: Accumulated Amortization	-657,830	-905,027
Total Intangible Assets, net	0	22,925
Goodwill	1,422,670	1,422,670
Other Assets	'	'
Deposits	133,488	12,855
Loans Receivable	1,430	2,046
Total Other Assets	134,918	14,901
TOTAL ASSETS	3,309,962	3,038,475
Current Liabilities	'	'
Accounts Payable	297,165	250,099
Accrued Taxes Payable	323,277	358,052
Obligations Under Capital Lease, short term portion	132,152	102,210
Acquisition Liability	0	200,000
Promissory Notes, short term portion	81,640	27,543
Loans Payable	75,000	0
Convertible Notes, net short term portion	55,164	0
Total Current Liabilities	964,398	937,904
Long Term Liabilities	'	'
Obligations Under Capital Lease, long term portion	157,262	228,495
Promissory Notes, long-term portion	10,262	17,472
Convertible Notes, net, long term portion	2,198,501	1,856,869
Total Long Term Liabilities	2,366,025	2,102,836
Total Liabilities	3,330,423	3,040,740
Stockholders' Equity (Deficit)	'	'
Preferred Stock	0	0
Common Stock	23,822	23,422
Additional Paid-In Capital	1,868,029	1,837,079
Accumulated Other Comprehensive Gain	6,437	6,708
Accumulated Deficit	-1,918,749	-1,869,474
Total Stockholders' Equity (Deficit)	-20,461	-2,265
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$3,309,962	$3,038,475

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Preferred stock, par value in dollars	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value in dollars	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	23,821,481	23,421,481
Common stock, shares outstanding	23,821,481	23,421,481

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue:	'	'	'	'
Sales	$1,316,125	$1,193,840	$2,512,062	$2,492,845
Less: Cost of Sales	796,126	766,244	1,501,621	1,570,120
Gross Margin	519,999	427,596	1,010,441	922,725
Operating Expenses:	'	'	'	'
Advertising	17,730	14,775	34,253	16,192
Amortization	0	34,387	22,925	68,773
Depreciation	39,835	39,486	79,655	78,922
Bad Debt Expense (Recapture)	7,458	-7,657	14,980	21,738
General and Administrative	53,974	58,945	108,497	104,929
Insurance	11,362	12,645	23,108	23,250
Labor	185,784	162,727	376,264	349,575
Legal and Professional	56,852	49,427	98,078	90,262
Management Fees	4,666	3,831	9,088	7,715
Rent Office Space and Servers	34,586	22,396	73,722	61,106
Travel	12,082	10,511	26,470	19,597
Total Operating Expenses	424,329	401,473	867,040	842,059
Income from Operations	95,670	26,123	143,401	80,666
Other Income and (Expenses):	'	'	'	'
Other Income	43	314	203	314
Debt Settlement Loss	0	0	0	-607
Foreign Currency Gains (Losses)	394	918	809	4,269
Amortization of Debt Discount	22,640	20,357	42,996	39,163
Interest Expense	82,467	75,914	150,692	146,425
Total Other Income (Expenses)	-104,670	-95,039	-192,676	-181,612
Income (Loss) Before Provision for Income Taxes	-9,000	-68,916	-49,275	-100,946
Provision for Income Taxes	0	0	0	0
Net Income (Loss)	-9,000	-68,916	-49,275	-100,946
Comprehensive Income (Loss)	-1,336	1,903	-271	3,290
Total Comprehensive Income (Loss)	($10,336)	($67,013)	($49,546)	($97,656)
Basic and Diluted Income (Loss) per Share	$0	($0.00)	($0.00)	($0.00)
Weighted Average Shares Outstanding - Basic and Diluted	23,767,195	23,421,481	23,605,790	23,278,937

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net Income (Loss)	($49,275)	($100,946)
Adjustments to Reconcile Net Loss to Net Cash provided by Operating Activities:	'	'
Depreciation	79,655	78,922
Asset Write Off	1,009	0
Accrued Interest Converted into note	132,707	118,802
Amortization of Debt Discount	42,996	39,163
Shares issued for services	150	0
Amortization of Intangible Assets	22,925	68,773
Foreign currency transaction Gain/ Loss	64	-3,394
Changes in operating assets and liabilities:	'	'
Accounts Receivable	-89,648	104,469
Deposits and prepaid expenses	-5,269	2,131
Accounts Payable and accrued liabilities	12,291	-88,495
Loans Receivable	616	1,087
NET CASH AND CASH EQUIVALENTS PROVIDED BY OPERATING ACTIVITIES	148,221	220,512
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Payments on acquisition liability	-110,062	0
Deposit on possible acquisition	-20,000	0
Deposit on equipment	-100,650	0
Equipment Purchase	-87,401	-14,166
NET CASH USED IN INVESTING ACTIVITIES	-318,113	-14,166
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Proceeds from debt issuance	445,000	156,000
Principal payments on Related Party debt	0	-8,905
Principal payments on debt	-160,758	-214,981
Principal Payments on Capital Lease Obligations	-41,291	-169,431
NET CASH AND CASH EQUIVALENTS USED IN FINANCING ACTIVITIES	242,951	-237,317
Gain (Loss) due to foreign currency translation	-271	3,290
NET CHANGE IN CASH AND CASH EQUIVALENTS	72,788	-27,681
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	77,300	107,701
CASH AND CASH EQUIVALENTS AT END OF PERIOD	150,088	80,020
Cash paid during the year for:	'	'
Interest	17,985	27,624
Income Taxes	36,555	0
Non-cash financing and investing activities:	'	'
Shares Issued for Convertible Note	31,200	18,600
Acquisition Liability Assigned to Loan Payable	64,937	0
Acquisition Liability Assigned to Promissory Note	$25,000	$0

Organization_and_Summary_of_Si

Organization and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Summary of Significant Accounting Policies	'
	Note 1. Organization and Summary of Significant Accounting Policies
	Organization and Basis of Presentation
	Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent facility located in Pottsville, Pennsylvania.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
	Principle of Consolidation
	The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, Custom Teleradiology Services, Inc. and Schuylkill Medical Imaging. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’ and SMI’s accumulated earnings prior to their acquisition (March 2, 2009 and December 10, 2012, respectively) are not included in the consolidated balance sheet.
	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the June 30, 2014 presentation.
	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At June 30, 2014, and December 31, 2013, cash includes cash on hand and cash in the bank.
	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. As of June 30, 2014 and December 31, 2013, the allowance for bad debts was $32,097 and $17,294, respectively.
	Bad debt expense for the six months ended June 30, 2014 and 2013 was $14,980 and $21,738, respectively.
	Bad debt expense for the three months ended June 30, 2014 was $7,458 and Bad debt recapture for the three months ended June 30, 2013 was $7,657.
	At June 30, 2014 two customers of CTS totalled approximately 44% of the total accounts receivable. As of December 31, 2013, three customers totalled approximately 70% of the total accounts receivable.
	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. As of June 30, 2014, the Company has goodwill of $1,422,670 as result of the acquisition of SMI on December 10, 2012. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
	Intangible Assets
	CTS has contracts with various hospitals in the province of Ontario, Canada. These contracts are for specific radiology services to be provided for a length of time. Contracts varied between one and five years. The contracts do not specify any minimum billings for any period of time. The contracts in existence on acquisition were valued on acquisition using a discounted cash flow model and the fair value as recorded is amortized over the remaining life of the contract using the straight line method.
	The Company has written off one of the hospital contracts to reflect end of service with no potential for renewal.
	The Company also attributed value to the non-compete agreement obtained as part of the acquisition agreement with CTS’ former director. As of June 30, 2014. The value attributed to this agreement has been fully amortized.
	SMI has a non-compete agreement with previous owners of SMI. The value attributed to this agreement has been fully amortized.
	Amortization of Intangible Assets
	The accumulated amortization of intangible assets with finite useful lives was $657,830 and $905,027 at June 30, 2014 and December 31, 2013, respectively.
	These assets have been fully amortized; therefore there is no expected amortization expense for the next five years.
	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the quarter ended June 30, 2014, CTS held seven contracts; one contract that is renewable on a year-to-year basis, four contracts that are renewable in 2014 ,2015, and 2016, and its two largest contracts, which renewed automatically in 2013 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, revenue is recorded at the time of service.
	Cost of Sales
	Cost of sales includes fees paid to radiologists for teleradiology services, transcription fees, equipment repairs, system license and usage costs.
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	3 - 7 years
	Equipment
	5 – 7 years
	Furniture and Fixtures
	2 to 5 years
	Hospital Contracts
	3 - 5 years
	Non-compete Contract
	39 years
	Leasehold Improvements
	Stock Based Compensation
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Black-Scholes option pricing model. The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the Black-Scholes option pricing model on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
	The Company did not recognize stock-based compensation expenses from stock granted to non-employees for the six and three months ended June 30, 2014 and 2013.
	The Company recognized stock-based compensation expenses of $150, and $0 from stock granted to employees for the six months ended June 30, 2014, and 2013, respectively.
	The Company did not recognize stock-based compensation expenses from stock granted to employees for the three months ended June 30, 2014 and 2013.
	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1
	Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
Level 3
Pricing inputs that are generally observable inputs and not corroborated by market data.
The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
The company does not have assets and liabilities that are carried at fair value on a recurring basis.
The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
The Company recognized a foreign currency gain on transactions from operations of $809 and $4,269 for the six months ended June 30, 2014 and 2013, respectively.
The Company recognized a foreign currency gain on transactions from operations of $394 and $918 for the three months ended June 30, 2014 and 2013, respectively.
The Company recognized other comprehensive loss of $271 and gain of $3,290 for the six months ended June 30, 2014 and 2013, respectively.
The Company recognized other comprehensive loss of $1,336 and gain of $1,903 for the three months ended June 30, 2014 and 2013, respectively.
Income Taxes
The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Net Income (Loss) Per Share
The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive. As of June 30, 2014, there were no stock options or stock awards that would have been included in the computation of diluted earnings per share that could potentially dilute basic earnings per share in the future.
The information related to basic and diluted earnings per share is as follows:
	Three Months Ending				Six Months Ending
	June 30,		June 30,		June 30,		June 30,
	2014		2013		2014		2013
Numerator:
Continuing operations:
Total Comprehensive Income (Loss)	$	-10,336	$	-67,013	$	-49,546	$	-97,656
Total	$	-10,336	$	-67,013	$	-49,546	$	-97,656
Total Comprehensive Income (Loss)	$	-10,336	$	-67,013	$	-49,546	$	-97,656
Denominator:
Weighted average number of shares outstanding – basic and diluted		23,767,195		23,421,481		23,605,790		23,278,937
EPS:
Basic:
Total Comprehensive Income (Loss)	$	0	$	-0.003	$	-0.002	$	-0.004
Net Income (loss)	$	0	$	-0.003	$	-0.002	$	-0.004
Diluted
Total Comprehensive Income (Loss)	$	0	$	-0.003	$	-0.002	$	-0.004
Total Comprehensive Income (Loss)	$	0	$	-0.003	$	-0.002	$	-0.004
Recent Accounting Updates
The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Interim_Financial_Statements

Interim Financial Statements	6 Months Ended
	Jun. 30, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Interim Financial Statements	'
	Note 2. Interim Financial Statements
	The accompanying interim unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six and three month period ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013.

Property_and_Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	Note 3. Property and Equipment
	In the quarter ending June 30, 2014 the Company made deposit payments of $100,650 towards the purchase of a CT machine that was delivered and put into operations in July 2014.
	In the quarter ending June 30, 2014 the Company made payments of $87,401 toward construction of an additional space designated for the CT machine. The construction of the CT room was completed in July 2014. The progress amounts paid were capitalized and classified as leasehold improvements.
	Property and equipment are stated at cost. Depreciation is calculated on the accelerated method over the estimated useful life of the assets. At June 30, 2014 and December 31, 2013, the major class of property and equipment were as follows:
		June 30,		December 31,		Estimated useful lives
		2014		2013
	Computer/Office Equipment	$	87,096	$	88,378	3-7 years
	Medical Equipment		601,774		601,774	3-7 years
	Leasehold Improvements		834,713		747,312	39 years
	Less: Accumulated Depreciation		-317,192		-237,763
	Net Book Value	$	1,206,391	$	1,199,701
	Depreciation expense was $79,655 and $78,922 for the six months ended June 30, 2014 and 2013, respectively.
	Depreciation expense was $39,835 and $39,486 for the three months ended June 30, 2014 and 2013, respectively.

Business_Combination

Business Combination	6 Months Ended
	Jun. 30, 2014
Business Combinations [Abstract]	'
Business Combination	'
	Note 4. Business Combination
	SMI acquisition:
	On December 10, 2012, the Company acquired 100% of Schuylkill Medical Imaging. for consideration including cash which is described in detail below. Accordingly, the results of operations for SMI have been included in the accompanying consolidated financial statements from that date forward. SMI provides Magnetic Resonance Imaging (MRI) services. Pursuant to the terms of the Share Purchase Agreement, the Company paid an aggregate purchase price of $1,825,000 for the shares, plus a possible earn-out payment of up to $200,000 to be paid within sixty days after December 31, 2013 if certain post-closing revenue targets are met. The earn out payment was paid out in June 2014.
	In connection with the Share Purchase Agreement, SMI entered into a lease agreement with one of the Sellers for the lease of two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000 which was fully paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
	Consideration for the acquisition comprised the following (at fair value):
	Cash	$	1,825,000
	Acquisition Liability		200,000
	Total consideration paid	$	2,025,000
	Following assets and liabilities were recognized in the acquisition (at fair value):
	Cash	$	42,887
	Accounts receivable		124,436
	Fixed Assets		1,345,647
	Deposits		8,140
	Non-compete agreement		27,917
	Goodwill		1,422,670
	Liabilities assumed		-946,697
	Net assets purchased	$	2,025,000
	The Company has evaluated this transaction and believes that the historical cost of the tangible and intangible assets acquired approximated fair market value given the current nature of the assets acquired. As part of the acquisition the Company has acquired Goodwill of $1,422,670. The Company expects to amortize the full amount of goodwill for tax purposes. At December 31, 2013 year end the Company performed an annual testing of goodwill for impairment, and valued the fair value of the reporting units to be greater than its carrying amount. As such, goodwill impairment was not recorded.
	The amounts of revenue included in the consolidated statement of operations for the six months ended June 30, 2014 and 2013 is $960,419, and $885,540, respectively.
	The amounts of gross earnings included in the consolidated statement of operations for six months ended June 30, 2014 and 2013 is $727,889, and $639,368, respectively.
	The amounts of revenue included in the consolidated statement of operations for the three months ended June 30, 2014 and 2013 is $502,454, and $409,524, respectively.
	The amounts of gross earnings included in the consolidated statement of operations for three months ended June 30, 2014 and 2013 is $371,834, and $294,134, respectively.
	Costs related to the acquisition, which include legal fees, in the amount of $81,811 have been charged directly to operations and are included in legal and professional expenses in the 2012 consolidated statement of operations.
	Prospective Acquisitions:
	On June 16, 2014, MIC entered into a Share Purchase Agreement (the “Share Purchase Agreement”) with the owners of a mobile diagnostic imaging company (the “Business”) located in Northern Florida. Pursuant to the terms of the Share Purchase Agreement, the Company was to purchase from the owners all of the outstanding capital stock of the Business for an aggregate purchase price of $3 million, consisting of $2.5 million in cash payable at closing and the issuance of a 12-month $500,000 promissory note, bearing interest at the rate of 5% per annum, payable at maturity, and secured by all of the personal property of the Business. Under the terms of the Share Purchase Agreement, the Company has made a refundable payment of $20,000 to the owners of the Business, which will be credited against the purchase price at closing. The refundable payment is shown on the consolidated balance sheet as a deposit.
	Consummation of the transaction was subject to certain customary closing conditions, including, among other things, the satisfactory completion of the Company’s due diligence review of the Business, the continued regulatory compliance of the Business, the completion of a financial audit of the Business which shall be acceptable to the Company, and the continued employment of specified personnel of the Business. Additionally, the acquisition of the Business may be abandoned by the Company at any time, in its sole discretion. On July 11, 2014 the Company terminated the Share Purchase Agreement with the owners of the business located in Northern Florida area and the deposit of $20,000 was refunded in July 2014.

Goodwill

Goodwill	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill	'
	Note 5. Goodwill
	The change in the carrying amount of goodwill for the two years ended June 30, 2014 was:
	Balance as of January 1, 2013	$	1,422,670
	Changes in goodwill during the year		-
	Balance as of December 31, 2013		1,422,670
	Changes in goodwill during the year		-
	Balance as of June 30, 2014	$	1,422,670

Lease_Commitments

Lease Commitments	6 Months Ended
	Jun. 30, 2014
Leases, Operating [Abstract]	'
Lease Commitments	'
	Note 6. Lease Commitments
	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $2,850 in utilities, realty taxes, and operating costs, for a total of approximately $5,300 per month. The Lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was given a rental credit of approximately $28,000. This lease was accounted for as an operating lease.
	CTS has a lease for its off-site servers at a cost of approximately $1,500 per month. This lease is accounted for as an operating lease. The lease will expire in April 30, 2017.
	SMI has a lease for its off-site servers at a cost of approximately $1,092 per month. This lease is accounted for as an operating lease on a month-to-month basis.
	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. Monthly rental amounts in 2014 were $5,437 per month plus approximately $1,674 in utilities, realty taxes, and operating costs. The lease was amended to include the additional space of 700 square feet occupied by the CT machine and equipment. The first additional rental payment will begin in July of 2015; the additional rental amount is expected to be approximately $1,100.
	SMI has a lease for office space in Dallas, Texas of approximately $880 per month plus approximately $660 in utilities, realty taxes, and operating costs. The lease will expire in February 28, 2015.
	Expected Lease commitments for the next three years:
	Year	Office Space		Servers		Total
	2014	$	83,706	$	15,552	$	99,258
	2015		158,612		31,104		189,716
	2016		112,866		31,104		143,970
		$	355,184	$	77,760	$	432,944

Accounts_Payable_and_Accrued_L

Accounts Payable and Accrued Liabilities	6 Months Ended
	Jun. 30, 2014
Payables and Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities	'
	Note 7. Accounts Payable and Accrued Liabilities
	As of June 30, 2013 and December 31, 2013, the trade payables and accrued liabilities of the Company were $620,442 and $608,151, respectively. Of the total amount as of June 30, 2014, approximately $267,581 is related to CTS operations and $298,063 is related to SMI operations. The balance of the accounts is for vendors supplying goods and services used in the normal course of business. Of the total amount as of December 31, 2013, approximately $301,965 is related to CTS operations and $278,854 is related to SMI operations. The balance of the accounts is for vendors supplying goods and services used in the normal course of business.

Obligations_Under_Capital_Leas

Obligations Under Capital Lease	6 Months Ended
	Jun. 30, 2014
Leases, Capital [Abstract]	'
Obligations Under Capital Lease	'
	Note 8. Obligations Under Capital Lease
	On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
	Minimum future lease payments under the capital lease are as follows as of June 30, 2014:
	2014		66,076
	2015		132,152
	2016		132,150
	Total minimum lease payments		330,378
	Less amount representing interest		40,964
	Present value of minimum lease payments		289,414
	Less current portion of minimum lease payments		132,152
	Long-term capital lease obligations	$	157,262
	The gross amount of the equipment held under capital leases totals $555,000 ($379,333 net book value after accumulated amortization of $175,667) at June 30, 2014.
	Amortization of the capital lease assets is included in the depreciation expense of $55,500, and $27,750 for the six and three months ending June 30, 2014, respectively.

Promissory_Notes

Promissory Notes	6 Months Ended
	Jun. 30, 2014
Other Liabilities Disclosure [Abstract]	'
Promissory Notes	'
	Note 9. Promissory Notes and Loans Payable
	Promissory Notes:
	During the year ended December 31, 2013, $6,616 in accrued interest was recorded on the notes, and $87,225 was paid towards the balance of the notes.$18,736 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 10.5% and paid out monthly. $45,792 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 6% and paid out monthly.
	During the six months ended June 30, 2014, $875 in accrued interest was recorded on the notes, and $18,925 was paid towards the balance of the notes.
	In June 2014 $64,937 of the acquisition liability that was due as part of SMI acquisition (see Note 4) was assigned to a promissory note accruing interest at an annual rate of 12%, and due on February 1, 2015. Interest accrued is to be paid out monthly with the principal amount due on maturity.
	A summary of the promissory notes is as follows:
	Promissory notes at January 1, 2013	$	119,624
	Added: Proceeds through December 31, 2013		6,000
	Added: Accrued Interest through December 31, 2013		6,616
	Less: Payments through December 31, 2013		-87,225
	Promissory notes at December 31, 2013	$	45,015
	Added: Note assigned through June 30, 2014		64,937
	Added: Accrued Interest through June 30, 2014		875
	Less: Payments through June 30, 2014		-18,925
	Promissory notes at June 30, 2014	$	91,902
	Less: Short term portion		81,640
	Long term portion June 30, 2014	$	10,262
	Loans Payable:
	In May 2014 the Company received proceeds of $50,000 through private placement from an accredited investor, and in June 2014 the Company assigned $25,000 of the acquisition liability that was due as part of SMI acquisition (see Note 4) to loans payable. The loans are held with the Company until it is registered with Pennsylvania Securities Commission and is permitted to sell to the Pennsylvania residents investors Series C convertible note.
	The total of $75,000 is shown on the consolidated balance sheets as loans payable until Series C notes can be issued.

Convertible_Notes

Convertible Notes	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Convertible Notes	'
	Note 10. Convertible Notes
	Series B:
	On December 3, 2012, the Company sold, through a private placement to accredited investors, three year 12% convertible notes (“Series B Notes”) in the aggregate principal amount of $1,865,000. On March 27, 2013 the Company sold an additional $150,000 of Series B Notes.
	Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month. The Notes are convertible into common shares of the Company at $0.10 per share. In addition, each holder of Series B Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares issued was 5,315,000 shares of common stock of the Company. $1,865,000 of Series B Notes issued on December 3, 2012 mature on December 31, 2013; and $150,000 of Series B Notes issued March 27, 2013 mature on March 31, 2016.
	For the six month ended June 30, 2014, $120,900 in accrued interest was recorded on the notes and paid.
	In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $244,275. Amortization of the discount for the six months ended June 30, 2014 was $40,713.
	The Details of Series B Notes are as follows:
	Issuance		December 31,			December 31,		Six Months		Six Months		Six Months		Six Months		June 30,		Maturity
	Date		2013			2013		Ended		Ended		Ended		Ended		2014		Date
			Balance			Unamortized		June 30,		June 30,		June 30,		June 30,		Balance, net
						Discount		2014		2014		2014		2014
						Beginning		Proceeds		Accrued		(Payments)		Amortization
						Balance				Interest				of Debt
														Discount
	3-Dec-12		$	25,000		$	-719	$	-	$	1,500	$	-1,500	$	188	$	24,469	31-Dec-15
	3-Dec-12			125,000			-10,569		-		7,500		-7,500		2,487		116,919	31-Dec-15
	3-Dec-12			50,000			-2,156		-		3,000		-3,000		563		48,406	31-Dec-15
	3-Dec-12			25,000			-719		-		1,500		-1,500		188		24,469	31-Dec-15
	3-Dec-12			25,000			-719		-		1,500		-1,500		188		24,469	31-Dec-15
	3-Dec-12			25,000			-719		-		1,500		-1,500		188		24,469	31-Dec-15
	3-Dec-12			1,500,000			-129,375		-		90,000		-90,000		33,750		1,404,375	31-Dec-15
	3-Dec-12			50,000			-2,156		-		3,000		-3,000		563		48,406	31-Dec-15
	3-Dec-12			15,000			-431		-		900		-900		113		14,681	31-Dec-15
	3-Dec-12			100,000			-7,081		-		6,000		-6,000		1,713		94,631	31-Dec-15
	27-Mar-13			25,000			-1,162		-		1,500		-1,500		258		24,096	31-Mar-16
	27-Mar-13			25,000			-1,162		-		1,500		-1,500		258		24,096	31-Mar-16
	27-Mar-13			25,000			-1,162		-		1,500		-1,500		258		24,096	31-Mar-16
	Total		$	2,015,000		$	-158,131	$	-	$	120,900	$	-120,900	$	40,713	$	1,897,582
	Summary of Series B Notes is as follows:
		June 30,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	2,015,000		$	2,015,000
	Less: unamortized debt discount		-117,418			-158,131
	Convertible notes principal, net		1,897,582			1,856,869
	Less: Payments in Period		-120,900			-235,300
	Added: Accrued interest		120,900			235,300
	Total Convertible notes, net	$	1,897,582		$	1,856,869
	Less: Short term portion, net		-			-
	Long term portion, net	$	1,897,582		$	1,856,869
	Following are maturities of the long –term debt in Series B Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	120,900	$	40,713
	2015			1,865,000			241,800		75,155
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	Total		$	2,015,000		$	367,200	$	117,418
	Series C:
	On May 22, 2014 the Company sold, through private placement to accredited investors, three year 12% convertible notes (“Series C Notes”) in the aggregate principal amount of $95,000.
	The Notes bear interest at a rate of 12% per annum, payable to the holder at1% per month, with the principal amount due on May 31, 2017. The Notes are convertible into shares of the Company’s common stock at an initial conversion rate of $0.15 per share. In addition, each holder of Series C Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares issued was 95,000 shares of common stock of the Company.
	In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $5,700. Amortization of the discount for the six months ended June 30, 2014, was $158.
	For the six month ended June 30, 2014, $1,218 in accrued interest was recorded on the notes and paid.
	Issuance		December 31,			Six Months		June 30,		Six Months		Six Months		Six Months		June 30,		Maturity
	Date		2013			Ended		2014		Ended		Ended		Ended		2014		Date
			Balance			June 30,		Unamortized		June 30,		June 30,		June 30,		Balance, net
						2014		Discount		2014		2014		2014
						Proceeds		Beginning		Accrued		(Payments)		Amortization
									Balance	Interest				of Debt
														Discount
	22-May-14		$	-		$	50,000	$	-3,000	$	642	$	-642	$	82	$	47,082	31-May-17
	22-May-14			-			22,500		-1,350		288		-288		38		21,188	31-May-17
	22-May-14			-			22,500		-1,350		288		-288		38		21,188	31-May-17
Total		$	-		$	95,000	$	-5,700	$	1,218	$	-1,218	$	158	$	89,458
Summary of Series C Notes is as follows:
	June 30,			December 31,
	2014			2013
Convertible notes Beginning Balance	$	95,000		$	-
Less: unamortized debt discount		-5,542			-
Convertible notes principal, net		89,458			-
Less: Payments in Period		-1,218			-
Added: Accrued interest		1,218			-
Total Convertible notes, net	$	89,458		$	-
Less: Short term portion, net		-			-
Long term portion, net	$	89,458		$	-
Following are maturities of the long –term debt in Series C Notes for each of the next 5 years:
		Principal			Interest		Amortization
		Payments			Payments		of Discount
2014		$	-		$	5,700	$	950
2015			-			11,400		1,900
2016			-			11,400		1,900
2017			95,000			4,750		792
2018			-			-		-
Total		$	95,000		$	32,250	$	5,542
Individually issued Convertible Note:
On March 26, 2014 the Company issued $300,000 in convertible note to a non-affiliate. The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. In addition to interest payments the Company will be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for three years until the note due date of February 27, 2017. The note is convertible into common shares of the Company at $0.15 per share. In addition, the non-affiliate will receive 300,000 shares as part of the note agreement.
For the six month ended June 30, 2014, $9,715 in accrued interest was recorded on the notes and paid.
In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $25,500. Amortization of the discount for the six months ended June 30, 2014 was $2,125.
Summary of the notes is as follows:
	June 30,			December 31,
	2014			2013
Convertible note Beginning Balance	$	300,000		$	-
Less: unamortized debt discount		-23,375			-
Convertible notes principal, net		276,625			-
Less: Payments in Period		-19,715			-
Added: Accrued interest		9,715			-
Total Convertible note, net	$	266,625		$	-
Less: short term portion, net		55,164			-
Long term portion, net	$	211,461		$	-
Following are maturity of the individually issued convertible note for each of the next 5 years:
		Principal			Interest		Amortization
		Payments			Payments		of Discount
2014		$	30,000		$	16,788	$	4,250
2015			60,000			27,884		8,500
2016			60,000			20,749		8,500
2017			140,000			2,625		2,125
2018			-			-		-
Total		$	290,000		$	68,046	$	23,375

Related_Party_Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Note 11. Related Party Transactions
	During the year ended December 31, 2013, Richard Jagodnik (an officer and shareholder of the Company), had a $7,062 note payable from MIC. The note was non-interest bearing and payable on demand. As at December 31, 2013 the note is fully paid.
	During the second quarter of 2010, Richard Jagodnik loaned MIC $42,944 under the same terms of convertible notes Series A. The note was carried in Canadian dollars and a foreign exchange gain of $693 was recorded for the year ended December 31, 2013. For the year ended December 31, 2013 $48 in accrued interest was recorded and added to the note. As at December 31, 2013 the note was fully paid.
	For the six months ended June 30, 2014 the Company did not have any related party debt outstanding.
	Summary of related party notes is as follows:
		Shareholder		Shareholder
		Note		Convertible Note
	Balance at January 1, 2013	$	7,062	$	10,936
	Added: Accrued Interest		-		48
	Less: Foreign Exchange Gain		-		693
	Less: Payments		-7,062		-10,291
	Balance at December 31, 2013	$	-	$	-
	Balance at June 30, 2014	$	-	$	-

Major_Customers

Major Customers	6 Months Ended
	Jun. 30, 2014
Major Customers	'
Major Customers	'
	Note 12. Major Customers
	For the six months ending June 30, 2014 and 2013, revenue was derived primarily from radiology services.
	Major customers representing more than 10% of total revenue for the six months ended June 30, 2014 and 2013 are as follow:
		Six Months Ended			Six Months Ended
		30-Jun-14			30-Jun-13
	Customers	Revenue		Revenue	Revenue		Revenue
		amount		percentage	amount		percentage
	Contract A	$	529,754	21%	$	576,141	23%
	Contract E		455,253	18%		529,133	21%
	Contract F		279,189	11%		281,610	11%
	Contract H	$	149,408	6%	$	131,060	5%
	Closing balances of accounts receivable for our major customers were as follow:
		Balance at			Balance at
		30-Jun-14			31-Dec-13
		Accounts		Accounts	Accounts		Accounts
		Receivable		Receivable	Receivable		Receivable
	Customers	Closing Balance		Percentage	Closing Balance		Percentage
	Contract A	$	18,485	5%	$	17,876	6%
	Contract E		106,730	28%		95,552	34%
	Contract F		50,883	13%		46,796	17%
	Contract H	$	24,843	6%	$	54,757	19%
	On May 8, 2014, the Company’s wholly-owned subsidiary, CTS, received notice that Contract A of its major customers is terminating its contract (the “Agreement”) with CTS. Pursuant to the terms of the Agreement, such termination is effective 90 days from the date of the notice.

Major_Vendors

Major Vendors	6 Months Ended
	Jun. 30, 2014
Major Vendors	'
Major Vendors	'
	Note 13. Major Vendors
	The Company has one major vendor providing its system software and support. Expenses relating to this vendor for the three months ended June 30, 2014 and 2013 were $14,610 and $13,811, respectively.

Common_Stock_Transactions

Common Stock Transactions	6 Months Ended
	Jun. 30, 2014
Equity [Abstract]	'
Common Stock Transactions	'
	Note 14. Common Stock Transactions
	For the six months ended June 30, 2014, 5,000 shares were issued for services valued at $150 based upon the closing price of our common stock at the grant date.
	For the six months ended June 30, 2014, 300,000 shares were issued as part of individually issued convertible note agreement. The shares were valued at $25,500 based upon the closing price of our common stock at the grant date.
	For the six months ended June 30, 2014, 95,000 shares were issued as part of series C convertible note agreement. The shares were valued at $5,700 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2013, 300,000 shares were issued as part of convertible notes agreements. The shares were valued at $18,600 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2012 5,015,000 shares were issued as an additional part of convertible notes agreements. The shares were valued at $225,675 based upon the closing price of our common stock at the grant date.

Income_Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 15. Income Tax
	The Company follows ASC 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between consolidated financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.
	The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure.
	Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.

Going_Concern

Going Concern	6 Months Ended
	Jun. 30, 2014
Going Concern	'
Going Concern	'
	Note. 16. Going Concern
	As shown in the accompanying consolidated financial statements, the Company incurred net losses of $10,336 for the three months ended June 30, 2014 as well as a working capital deficit of $418,415. These conditions raise substantial doubt as to if the Company’s ability to continue as a going concern. Management plan to raise additional financing in order to continue its operations and fulfil its debt obligations in 2015, but there can be no assurances that the plan will be successful. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Subsequent_Events

Subsequent Events	6 Months Ended
	Jun. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Note 17. Subsequent events
	Subsequent to quarter end, the Company terminated the Share Purchase Agreement with the owners of the business located in Northern Florida area and the deposit of $20,000 was refunded in July 2014 (see Note 4).
	Subsequent to quarter end, the Company has completed the purchase of a CT and an x-ray machine for its SMI location. SMI has purchased a 16 Slice Toshiba Aquillion CT and a Viztek Digital Direct Radiography Straight Arm x-ray System. Both machines were delivered and installed prior to the end of July 2014. In addition SMI has completed building CT and x-ray rooms prior to house the additional machines. Both new machines were put in operation at the end of July 2014.
	Subsequent to quarter end, the Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. The gross amount of the x-ray machine held under the capital lease is $78,500.
	Subsequent to quarter end, The Company’s subsidiary, SMI, has entered into a sublease agreement for approximately one hundred fifty (150) square feet of space for the use of operating the x-ray machine as well as use of common areas of the sublessor. The lease calls for monthly payments of $2,000 beginning October 1, 2014.
	The Company evaluated subsequent events through the date the consolidated financial statements were issued.

Accounting_Policies_Policies

Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Organization and Basis of Presentation	'
	Organization and Basis of Presentation
	Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent facility located in Pottsville, Pennsylvania.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Principle of Consolidation	'
	Principle of Consolidation
	The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, Custom Teleradiology Services, Inc. and Schuylkill Medical Imaging. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’ and SMI’s accumulated earnings prior to their acquisition (March 2, 2009 and December 10, 2012, respectively) are not included in the consolidated balance sheet.
Reclassification of Accounts	'
	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the June 30, 2014 presentation.
Use of Estimates and Assumptions	'
	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Accounts Receivable Credit Risk	'
	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables.
Goodwill and Indefinite Intangible Assets	'
	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
Intangible Assets	'
	Intangible Assets
	CTS has contracts with various hospitals in the province of Ontario, Canada. These contracts are for specific radiology services to be provided for a length of time. Contracts varied between one and five years. The contracts do not specify any minimum billings for any period of time. The contracts in existence on acquisition were valued on acquisition using a discounted cash flow model and the fair value as recorded is amortized over the remaining life of the contract using the straight line method.
Revenue Recognition	'
	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the quarter ended June 30, 2014, CTS held seven contracts; one contract that is renewable on a year-to-year basis, four contracts that are renewable in 2014 ,2015, and 2016, and its two largest contracts, which renewed automatically in 2013 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, revenue is recorded at the time of service.
Cost of Sales	'
	Cost of Sales
	Cost of sales includes fees paid to radiologists for teleradiology services, transcription fees, equipment repairs, system license and usage costs.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Amortization and Depreciation	'
	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	3 - 7 years
	Equipment
	5 – 7 years
	Furniture and Fixtures
	2 to 5 years
	Hospital Contracts
	3 - 5 years
	Non-compete Contract
	39 years
	Leasehold Improvements
Stock Based Compensation	'
	Stock Based Compensation
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Black-Scholes option pricing model. The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the Black-Scholes option pricing model on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
Fair Value Measurements	'
	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1
	Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2
	Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
	Level 3
	Pricing inputs that are generally observable inputs and not corroborated by market data.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
	The company does not have assets and liabilities that are carried at fair value on a recurring basis.
	The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Net Income/ (Loss) Per Share	'
	Net Income (Loss) Per Share
	The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
	Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive.
Recent Accounting Updates	'
	Recent Accounting Updates
	The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Organization_and_Summary_of_Si1

Organization and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Schedule of Earnings Per Share	'
		Three Months Ending				Six Months Ending
		June 30,		June 30,		June 30,		June 30,
		2014		2013		2014		2013
	Numerator:
	Continuing operations:
	Total Comprehensive Income (Loss)	$	-10,336	$	-67,013	$	-49,546	$	-97,656
	Total	$	-10,336	$	-67,013	$	-49,546	$	-97,656
	Total Comprehensive Income (Loss)	$	-10,336	$	-67,013	$	-49,546	$	-97,656
	Denominator:
	Weighted average number of shares outstanding – basic and diluted		23,767,195		23,421,481		23,605,790		23,278,937
	EPS:
	Basic:
	Total Comprehensive Income (Loss)	$	0	$	-0.003	$	-0.002	$	-0.004
	Net Income (loss)	$	0	$	-0.003	$	-0.002	$	-0.004
	Diluted
	Total Comprehensive Income (Loss)	$	0	$	-0.003	$	-0.002	$	-0.004
	Total Comprehensive Income (Loss)	$	0	$	-0.003	$	-0.002	$	-0.004

Property_and_Equipment_Tables

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property Plant and Equipment	'
		June 30,		December 31,		Estimated useful lives
		2014		2013
	Computer/Office Equipment	$	87,096	$	88,378	3-7 years
	Medical Equipment		601,774		601,774	3-7 years
	Leasehold Improvements		834,713		747,312	39 years
	Less: Accumulated Depreciation		-317,192		-237,763
	Net Book Value	$	1,206,391	$	1,199,701

Business_Combination_Tables

Business Combination (Tables)	6 Months Ended
	Jun. 30, 2014
Business Combinations [Abstract]	'
Schedule of Purchase Price Allocation	'
	Cash	$	1,825,000
	Acquisition Liability		200,000
	Total consideration paid	$	2,025,000
Schedule of Recognized Assets Acquired and Liabilities Assumed	'
	Cash	$	42,887
	Accounts receivable		124,436
	Fixed Assets		1,345,647
	Deposits		8,140
	Non-compete agreement		27,917
	Goodwill		1,422,670
	Liabilities assumed		-946,697
	Net assets purchased	$	2,025,000

Goodwill_Tables

Goodwill (Tables)	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill	'
	Balance as of January 1, 2013	$	1,422,670
	Changes in goodwill during the year		-
	Balance as of December 31, 2013		1,422,670
	Changes in goodwill during the year		-
	Balance as of June 30, 2014	$	1,422,670

Lease_Commitments_Tables

Lease Commitments (Tables)	6 Months Ended
	Jun. 30, 2014
Leases, Operating [Abstract]	'
Schedule of Lease Commitments	'
	Year	Office Space		Servers		Total
	2014	$	83,706	$	15,552	$	99,258
	2015		158,612		31,104		189,716
	2016		112,866		31,104		143,970
		$	355,184	$	77,760	$	432,944

Obligations_Under_Capital_Leas1

Obligations Under Capital Lease (Tables)	6 Months Ended
	Jun. 30, 2014
Leases, Capital [Abstract]	'
Schedule of Future Minimum Lease Payments for Capital Leases	'
	2014		66,076
	2015		132,152
	2016		132,150
	Total minimum lease payments		330,378
	Less amount representing interest		40,964
	Present value of minimum lease payments		289,414
	Less current portion of minimum lease payments		132,152
	Long-term capital lease obligations	$	157,262

Promissory_Notes_Tables

Promissory Notes (Tables)	6 Months Ended
	Jun. 30, 2014
Other Liabilities Disclosure [Abstract]	'
Schedule of Promissory Notes	'
	Promissory notes at January 1, 2013	$	119,624
	Added: Proceeds through December 31, 2013		6,000
	Added: Accrued Interest through December 31, 2013		6,616
	Less: Payments through December 31, 2013		-87,225
	Promissory notes at December 31, 2013	$	45,015
	Added: Note assigned through June 30, 2014		64,937
	Added: Accrued Interest through June 30, 2014		875
	Less: Payments through June 30, 2014		-18,925
	Promissory notes at June 30, 2014	$	91,902
	Less: Short term portion		81,640
	Long term portion June 30, 2014	$	10,262

Convertible_Notes_Tables

Convertible Notes (Tables)	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt	'
	The Details of Series B Notes are as follows:
	Issuance		December 31,			December 31,		Six Months		Six Months		Six Months		Six Months		June 30,		Maturity
	Date		2013			2013		Ended		Ended		Ended		Ended		2014		Date
			Balance			Unamortized		June 30,		June 30,		June 30,		June 30,		Balance, net
						Discount		2014		2014		2014		2014
						Beginning		Proceeds		Accrued		(Payments)		Amortization
						Balance				Interest				of Debt
														Discount
	3-Dec-12		$	25,000		$	-719	$	-	$	1,500	$	-1,500	$	188	$	24,469	31-Dec-15
	3-Dec-12			125,000			-10,569		-		7,500		-7,500		2,487		116,919	31-Dec-15
	3-Dec-12			50,000			-2,156		-		3,000		-3,000		563		48,406	31-Dec-15
	3-Dec-12			25,000			-719		-		1,500		-1,500		188		24,469	31-Dec-15
	3-Dec-12			25,000			-719		-		1,500		-1,500		188		24,469	31-Dec-15
	3-Dec-12			25,000			-719		-		1,500		-1,500		188		24,469	31-Dec-15
	3-Dec-12			1,500,000			-129,375		-		90,000		-90,000		33,750		1,404,375	31-Dec-15
	3-Dec-12			50,000			-2,156		-		3,000		-3,000		563		48,406	31-Dec-15
	3-Dec-12			15,000			-431		-		900		-900		113		14,681	31-Dec-15
	3-Dec-12			100,000			-7,081		-		6,000		-6,000		1,713		94,631	31-Dec-15
	27-Mar-13			25,000			-1,162		-		1,500		-1,500		258		24,096	31-Mar-16
	27-Mar-13			25,000			-1,162		-		1,500		-1,500		258		24,096	31-Mar-16
	27-Mar-13			25,000			-1,162		-		1,500		-1,500		258		24,096	31-Mar-16
	Total		$	2,015,000		$	-158,131	$	-	$	120,900	$	-120,900	$	40,713	$	1,897,582
	The Details of Series C Notes are as follows:
	Issuance		December 31,			Six Months		June 30,		Six Months		Six Months		Six Months		June 30,		Maturity
	Date		2013			Ended		2014		Ended		Ended		Ended		2014		Date
			Balance			June 30,		Unamortized		June 30,		June 30,		June 30,		Balance, net
						2014		Discount		2014		2014		2014
						Proceeds		Beginning		Accrued		(Payments)		Amortization
									Balance	Interest				of Debt
														Discount
	22-May-14		$	-		$	50,000	$	-3,000	$	642	$	-642	$	82	$	47,082	31-May-17
	22-May-14			-			22,500		-1,350		288		-288		38		21,188	31-May-17
	22-May-14			-			22,500		-1,350		288		-288		38		21,188	31-May-17
	Total		$	-		$	95,000	$	-5,700	$	1,218	$	-1,218	$	158	$	89,458
Schedule of Debt Summary	'
	Summary of Series B Notes is as follows:
		June 30,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	2,015,000		$	2,015,000
	Less: unamortized debt discount		-117,418			-158,131
	Convertible notes principal, net		1,897,582			1,856,869
	Less: Payments in Period		-120,900			-235,300
	Added: Accrued interest		120,900			235,300
	Total Convertible notes, net	$	1,897,582		$	1,856,869
	Less: Short term portion, net		-			-
	Long term portion, net	$	1,897,582		$	1,856,869
	Summary of Series C Notes is as follows:
		June 30,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	95,000		$	-
	Less: unamortized debt discount		-5,542			-
	Convertible notes principal, net		89,458			-
	Less: Payments in Period		-1,218			-
	Added: Accrued interest		1,218			-
	Total Convertible notes, net	$	89,458		$	-
	Less: Short term portion, net		-			-
	Long term portion, net	$	89,458		$	-
	Summary of Individual Convertible Notes is as follows:
		June 30,			December 31,
		2014			2013
	Convertible note Beginning Balance	$	300,000		$	-
	Less: unamortized debt discount		-23,375			-
	Convertible notes principal, net		276,625			-
	Less: Payments in Period		-19,715			-
	Added: Accrued interest		9,715			-
	Total Convertible note, net	$	266,625		$	-
	Less: short term portion, net		55,164			-
	Long term portion, net	$	211,461		$	-
Schedule of Maturities of Long Term Debt	'
	Following are maturities of the long –term debt in Series B Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	120,900	$	40,713
	2015			1,865,000			241,800		75,155
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	Total		$	2,015,000		$	367,200	$	117,418
	Following are maturities of the long –term debt in Series C Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	5,700	$	950
	2015			-			11,400		1,900
	2016			-			11,400		1,900
	2017			95,000			4,750		792
	2018			-			-		-
	Total		$	95,000		$	32,250	$	5,542
	Following are maturity of the individually issued convertible note for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	30,000		$	16,788	$	4,250
	2015			60,000			27,884		8,500
	2016			60,000			20,749		8,500
	2017			140,000			2,625		2,125
	2018			-			-		-
	Total		$	290,000		$	68,046	$	23,375

Related_Party_Transaction_Tabl

Related Party Transaction (Tables)	6 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Schedule of Related Party Transactions	'
		Shareholder		Shareholder
		Note		Convertible Note
	Balance at January 1, 2013	$	7,062	$	10,936
	Added: Accrued Interest		-		48
	Less: Foreign Exchange Gain		-		693
	Less: Payments		-7,062		-10,291
	Balance at December 31, 2013	$	-	$	-
	Balance at June 30, 2014	$	-	$	-

Major_Customers_Tables

Major Customers (Tables)	6 Months Ended
	Jun. 30, 2014
Major Customers	'
Schedule of Revenue by Major Customers	'
		Six Months Ended			Six Months Ended
		30-Jun-14			30-Jun-13
	Customers	Revenue		Revenue	Revenue		Revenue
		amount		percentage	amount		percentage
	Contract A	$	529,754	21%	$	576,141	23%
	Contract E		455,253	18%		529,133	21%
	Contract F		279,189	11%		281,610	11%
	Contract H	$	149,408	6%	$	131,060	5%
Schedule of Accounts Receivable by Major Customers	'
		Balance at			Balance at
		30-Jun-14			31-Dec-13
		Accounts		Accounts	Accounts		Accounts
		Receivable		Receivable	Receivable		Receivable
	Customers	Closing Balance		Percentage	Closing Balance		Percentage
	Contract A	$	18,485	5%	$	17,876	6%
	Contract E		106,730	28%		95,552	34%
	Contract F		50,883	13%		46,796	17%
	Contract H	$	24,843	6%	$	54,757	19%

Organization_and_Summary_of_Si2

Organization and Summary of Significant Accounting Policies - Basic and Diluted Earners Per Share (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Numerator	'	'	'	'
Total comprehensive income (loss)	($10,336)	($67,013)	($49,546)	($97,656)
Denominator	'	'	'	'
Weighted average number of shares outstanding - basic and diluted	23,767,195	23,421,481	23,605,790	23,278,937
Earnings per Share	'	'	'	'
Basic earnings per share from total comprehensive income (loss)	$0	($0.00)	($0.00)	($0.00)
Diluted earnings per share from total comprehensive income (loss)	$0	($0.00)	($0.00)	($0.00)

Organization_and_Summary_of_Si3

Organization and Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Accounts Receivable, Net, Current	'	'	'	'	'	'
Allowance for bad debts	$32,097	'	$32,097	'	$17,294	'
Bad debt expense (recapture)	7,458	-7,657	14,980	21,738	'	'
Accounts receivable, concentration risk	'	'	44.00%	'	70.00%	'
Goodwill and Indefinite Intangible Assets	'	'	'	'	'	'
Goodwill	1,422,670	'	1,422,670	'	1,422,670	0
Amortization of Intangible Assets with Finite Useful Lives	'	'	'	'	'	'
Accumulated amortization	-657,830	'	-657,830	'	-905,027	'
Recognized Share-Based Compensation Expense	'	'	'	'	'	'
Stock-based compensation expense	'	'	150	0	'	'
Other Income and (Expenses):	'	'	'	'	'	'
Foreign currency gains (losses)	394	918	809	4,269	'	'
Other comprehensive income (loss) gain	($1,336)	$1,903	($271)	$3,290	'	'

Organization_and_Summary_of_Si4

Organization and Summary of Significant Accounting Policies - PPE Amortization and Depreciation (Details Narrative)	6 Months Ended
	Jun. 30, 2014
Equipment	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'3 - 7 years
Furniture and Fixtures	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'5 - 7 years
Hospital Contracts	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'2 - 5 years
Non-compete Contract	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'3 - 5 years
Leasehold Improvements	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'39 years

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	6 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, accumulated depreciation	($317,192)	($237,763)
Property and equipment, net	1,206,391	1,199,701
Computer/Office Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	87,096	88,378
Property and equipment, estimated useful lives	'3 - 7 years	'
Medical Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	601,774	601,774
Property and equipment, estimated useful lives	'3 - 7 years	'
Leasehold Improvements	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$834,713	$747,312
Property and equipment, estimated useful lives	'39 years	'

Property_and_Equipment_Details1

Property and Equipment (Details Narrative) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Property, Plant and Equipment [Abstract]	'	'	'	'
Depreciation expense	$39,835	$39,486	$79,655	$78,922
Payments to acquire equipment	100,650	'	'	'
Payment for construction process	$87,401	'	'	'

Business_Combination_Considera

Business Combination - Consideration Transfered (Details) (USD $)	6 Months Ended
	Jun. 30, 2014
Business Combination, Consideration Transferred	'
Cash consideration paid	$1,825,000
Acquisition Liability	200,000
Total consideration paid	$2,025,000

Business_Combination_Recognize

Business Combination - Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Combinations [Abstract]	'	'	'
Fair value of cash acquired	$42,887	'	'
Fair value accounts receivable acquired	124,436	'	'
Fair value fixed assets acquired	1,345,647	'	'
Fair value deposits acquired	8,140	'	'
Fair value non-compete agreement acquired	27,917	'	'
Fair value goodwill acquired	1,422,670	1,422,670	0
Fair value liabilities assumed	-946,697	'	'
Fair value net assets purchased	$2,025,000	'	'

Business_Combination_Details_N

Business Combination (Details Narrative) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2012	Dec. 10, 2012
Business Combinations [Abstract]	'	'	'	'	'	'
Business combination, name of acquired entity	'	'	'	'	'Schuylkill Open MRI Inc	'
Business combination, description of acquired entity	'	'	'	'	'SMI provides Magnetic Resonance Imaging (MRI) services.	'
Business combination, date of acquisition	'	'	'	'	10-Dec-12	'
Business combination, capital lease agreement	'	'	'	'	'	$11,013
Business combination, one-time capital lease payment	'	'	'	'	'	125,000
Business combination, capital lease, value	'	'	'	'	'	555,000
Business combination, option to purchase equipment	'	'	'	'	'On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI's obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.	'
Business combination, revenue through acquired entity	502,454	409,524	960,419	885,540	'	'
Business combination, gross earnings through acquired entity	371,834	294,134	727,889	639,368	'	'
Business combination, costs related to the acquisition	'	'	'	'	$81,811	'
Prospective acquisition consideration and outcome	'	'	'On June 16, 2014, MIC entered into a Share Purchase Agreement with the owners of a mobile diagnostic imaging company located in Northern Florida. Pursuant to the terms of the Share Purchase Agreement, the Company was to purchase from the owners all of the outstanding capital stock of the Business for an aggregate purchase price of $3 million, consisting of $2.5 million in cash payable at closing and the issuance of a 12-month $500,000 promissory note, bearing interest at the rate of 5% per annum, payable at maturity, and secured by all of the personal property of the Business. Under the terms of the Share Purchase Agreement, the Company has made a refundable payment of $20,000 to the owners of the Business, which will be credited against the purchase price at closing. The refundable payment is shown on the consolidated balance sheet as a deposit. Consummation of the transaction was subject to certain customary closing conditions, including, among other things, the satisfactory completion of the Company's due diligence review of the Business, the continued regulatory compliance of the Business, the completion of a financial audit of the Business which shall be acceptable to the Company, and the continued employment of specified personnel of the Business. On July 11, 2014 the Company terminated the Share Purchase Agreement with the owners of the business located in Northern Florida area and the deposit of $20,000 was refunded in July 2014.	'	'	'

Goodwill_Details

Goodwill (Details) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Goodwill [Roll Forward]	'	'
Goodwill, balance at beginning of period	$1,422,670	$0
Changes in Goodwill	0	0
Goodwill, balance at end of period	$1,422,670	$1,422,670

Lease_Commitments_Details

Lease Commitments (Details) (USD $)	Jun. 30, 2014
Office Space	'
Operating Leased Assets [Line Items]	'
Year 2014	$83,706
Year 2015	158,612
Year 2016	112,866
Servers	'
Operating Leased Assets [Line Items]	'
Year 2014	15,552
Year 2015	31,104
Year 2016	31,104
Total Lease Commitments	'
Operating Leased Assets [Line Items]	'
Year 2014	99,258
Year 2015	189,716
Year 2016	$143,970

Lease_Commitments_Details_Narr

Lease Commitments (Details Narrative) (USD $)	6 Months Ended
	Jun. 30, 2014
CTS - Office Space	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	$5,300
Leasing arrangements	'CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $2,850 in utilities, realty taxes, and operating costs. The Lease renewed in April 2013 for a period of five years and will expire in March 2018.
Rental credit	28,000
CTS - Off Site Servers	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	15,000
Leasing arrangements	'CTS has a lease for its off-site servers. The lease will expire in April 30, 2017.
SMI - Off Site Server	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	1,092
Leasing arrangements	'SMI has a lease for its off-site servers. The lease is accounted for as an operating lease on a month-to-month basis.
SMI - Office Space - Pottsville, Pennsylvania	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	7,111
Leasing arrangements	'SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. The lease was amended to include the additional space of 700 square feet occupied by the CT machine and equipment. The first additional rental payment will begin in July of 2015; the additional rental amount is expected to be approximately $1,100.
SMI - Office Space - Dallas, Texas	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	$1,540
Leasing arrangements	'SMI has a lease for its off-site servers. The lease is accounted for as an operating lease on a month-to-month basis.

Accounts_Payable_and_Accrued_L1

Accounts Payable and Accrued Liabilities (Details Narrative) (USD $)	Jun. 30, 2014	Dec. 31, 2013
TradePayablesAndAccruedLiabilitiesLineItems [Line Items]	'	'
Trade payables and accrued expenses	$620,442	$608,151
CTS - Ongoing Operations	'	'
TradePayablesAndAccruedLiabilitiesLineItems [Line Items]	'	'
Trade payables and accrued expenses	267,581	301,965
SMI - Ongoing Operations	'	'
TradePayablesAndAccruedLiabilitiesLineItems [Line Items]	'	'
Trade payables and accrued expenses	$298,063	$278,854

Obligations_Under_Capital_Leas2

Obligations Under Capital Lease (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Capital Leases Future Minimum Payments Due Rolling Maturity	'	'
Minimum future lease payments, 2014	$66,076	'
Minimum future lease payments, 2015	132,152	'
Minimum future lease payments, 2016	132,150	'
Total minimum lease payments	330,378	'
Less amount representing interest	40,964	'
Present value of minimum lease payments	289,414	'
Less current portion of minimum lease payments	-132,152	'
Obligations Under Capital Lease, long term portion	$157,262	$228,495

Obligations_Under_Capital_Leas3

Obligations Under Capital Lease (Details Narrative) (USD $)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Dec. 31, 2012
Leases, Capital [Abstract]	'	'	'
Capital leases, equipment, gross	$555,000	$555,000	'
Capital leases, equipment, net	379,333	379,333	'
Capital leases, amortization expense	'	175,667	'
Amortization of leased assets	$27,750	$55,500	'
Capital leases, leasing arrangements	'	'	'On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI's obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.

Promissory_Notes_Details

Promissory Notes (Details) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Promissory Notes [Roll Forward]	'	'
Promissory notes, beginning of period	$45,015	$119,624
Proceeds from Notes Issuances	'	6,000
Promissory note assigned	64,937	'
Accrued interest	875	6,616
Payments through end of period	-18,925	-87,225
Promissory notes, end of period	91,902	45,015
Promissory notes, short-term portion	81,640	'
Promissory Notes, long-term portion	$10,262	$17,472

Promissory_Notes_Details_Narra

Promissory Notes (Details Narrative) (USD $)	6 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Other Liabilities Disclosure [Abstract]	'	'
Accrued interest rate, terms	'$18,736 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 10.5% and paid out monthly. $45,792 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 6% and paid out monthly.	'
Promissory note, interest rate	12.00%	'
Promissory note, maturity date	1-Feb-15	'
Loans Payable	$75,000	$0

Convertible_Notes_Details_1

Convertible Notes (Details 1) (USD $)	6 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Convertible note, maturity date	1-Feb-15	'
Series B - Note 1	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	$25,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	1,500	'
Convertible note, payments	-1,500	'
Convertible note, amortization of debt discount	188	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,469	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 2	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	125,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	7,500	'
Convertible note, payments	-7,500	'
Convertible note, amortization of debt discount	2,487	'
Convertible note, unamortized debt discount	'	-10,569
Convertible note, ending balance	116,919	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 3	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	50,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	3,000	'
Convertible note, payments	-3,000	'
Convertible note, amortization of debt discount	563	'
Convertible note, unamortized debt discount	'	-2,156
Convertible note, ending balance	48,406	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 4	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	25,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	1,500	'
Convertible note, payments	-1,500	'
Convertible note, amortization of debt discount	188	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,469	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 5	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	2,500	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	1,500	'
Convertible note, payments	-1,500	'
Convertible note, amortization of debt discount	188	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,469	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 6	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	2,500	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	1,500	'
Convertible note, payments	-1,500	'
Convertible note, amortization of debt discount	188	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,469	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 7	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	1,500,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	90,000	'
Convertible note, payments	-90,000	'
Convertible note, amortization of debt discount	33,750	'
Convertible note, unamortized debt discount	'	-129,375
Convertible note, ending balance	1,404,375	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 8	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	50,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	3,000	'
Convertible note, payments	-3,000	'
Convertible note, amortization of debt discount	563	'
Convertible note, unamortized debt discount	'	-2,156
Convertible note, ending balance	48,406	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 9	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	31-Dec-12	'
Convertible note, beginning balance	15,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	900	'
Convertible note, payments	-900	'
Convertible note, amortization of debt discount	113	'
Convertible note, unamortized debt discount	'	-431
Convertible note, ending balance	14,681	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 10	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	100,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	6,000	'
Convertible note, payments	-6,000	'
Convertible note, amortization of debt discount	1,713	'
Convertible note, unamortized debt discount	'	-7,081
Convertible note, ending balance	94,631	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 11	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	27-Mar-13	'
Convertible note, beginning balance	25,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	1,500	'
Convertible note, payments	-1,500	'
Convertible note, amortization of debt discount	258	'
Convertible note, unamortized debt discount	'	-1,162
Convertible note, ending balance	24,096	'
Convertible note, maturity date	31-Mar-16	'
Series B - Note 12	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	27-Mar-13	'
Convertible note, beginning balance	25,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	1,500	'
Convertible note, payments	-1,500	'
Convertible note, amortization of debt discount	258	'
Convertible note, unamortized debt discount	'	-1,162
Convertible note, ending balance	24,096	'
Convertible note, maturity date	31-Mar-16	'
Series B - Note 13	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	27-Mar-13	'
Convertible note, beginning balance	25,000	'
Convertible note, proceeds	0	'
Convertible note, accrued interest	1,500	'
Convertible note, payments	-1,500	'
Convertible note, amortization of debt discount	258	'
Convertible note, unamortized debt discount	'	-1,162
Convertible note, ending balance	24,096	'
Convertible note, maturity date	31-Mar-16	'
Series C - Note 1	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	22-May-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	50,000	'
Convertible note, accrued interest	642	'
Convertible note, payments	-642	'
Convertible note, amortization of debt discount	82	'
Convertible note, unamortized debt discount	-3,000	'
Convertible note, ending balance	47,082	'
Convertible note, maturity date	31-May-17	'
Series C - Note 2	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	22-May-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	22,500	'
Convertible note, accrued interest	288	'
Convertible note, payments	-288	'
Convertible note, amortization of debt discount	38	'
Convertible note, unamortized debt discount	-1,350	'
Convertible note, ending balance	21,188	'
Convertible note, maturity date	31-May-17	'
Series C - Note 3	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	22-May-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	22,500	'
Convertible note, accrued interest	288	'
Convertible note, payments	-288	'
Convertible note, amortization of debt discount	38	'
Convertible note, unamortized debt discount	-1,350	'
Convertible note, ending balance	$21,188	'
Convertible note, maturity date	31-May-17	'

Convertible_Notes_Details_2

Convertible Notes (Details 2) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Series B - Convertible Notes	'	'
Debt Instrument [Line Items]	'	'
Convertible notes, beginning of period	$2,015,000	$2,015,000
Less: unamortized debt discount	-117,418	-158,131
Convertible notes principal, net	1,897,582	1,856,869
Less: Payment in period	-120,900	-235,300
Added: Accrued interest	120,900	235,300
Total convertible notes, net	1,897,582	1,856,869
Less: Short term portion, net	0	0
Long term portion, net	1,897,582	1,856,869
Series C - Convertible Notes	'	'
Debt Instrument [Line Items]	'	'
Convertible notes, beginning of period	95,000	0
Less: unamortized debt discount	-5,542	0
Convertible notes principal, net	89,458	0
Less: Payment in period	-1,218	0
Added: Accrued interest	1,218	0
Total convertible notes, net	89,458	0
Less: Short term portion, net	0	0
Long term portion, net	89,458	0
Individually Issued Convertible Note	'	'
Debt Instrument [Line Items]	'	'
Convertible notes, beginning of period	300,000	0
Less: unamortized debt discount	-23,375	0
Convertible notes principal, net	276,625	0
Less: Payment in period	-19,715	0
Added: Accrued interest	9,715	0
Total convertible notes, net	266,625	0
Less: Short term portion, net	55,164	0
Long term portion, net	$211,461	$0

Convertible_Notes_Details_3

Convertible Notes (Details 3) (USD $)	6 Months Ended
	Jun. 30, 2014
Series B Notes - Long-Term Debt Maturities	'
LongTermDebtMaturitiesLineItems [Line Items]	'
Principal payments, 2014	$0
Principal payments, 2015	1,865,000
Principal payments, 2016	150,000
Principal payments, 2017	0
Principal payments, 2018	0
Interest payments, 2014	120,900
Interest payments, 2015	241,800
Interest payments, 2016	4,500
Interest payments, 2017	0
Interest payments, 2018	0
Amortization expense, 2014	40,713
Amortization expense, 2015	75,155
Amortization expense, 2016	1,550
Amortization expense, 2017	0
Amortization expense, 2018	0
Series C Notes - LongTerm Debt Maturities	'
LongTermDebtMaturitiesLineItems [Line Items]	'
Principal payments, 2014	0
Principal payments, 2015	0
Principal payments, 2016	0
Principal payments, 2017	95,000
Principal payments, 2018	0
Interest payments, 2014	5,700
Interest payments, 2015	11,400
Interest payments, 2016	11,400
Interest payments, 2017	4,750
Interest payments, 2018	0
Amortization expense, 2014	950
Amortization expense, 2015	1,900
Amortization expense, 2016	1,900
Amortization expense, 2017	792
Amortization expense, 2018	0
Non-Affiliate Issued Convertible Note	'
LongTermDebtMaturitiesLineItems [Line Items]	'
Principal payments, 2014	30,000
Principal payments, 2015	60,000
Principal payments, 2016	60,000
Principal payments, 2017	140,000
Principal payments, 2018	0
Interest payments, 2014	16,788
Interest payments, 2015	27,884
Interest payments, 2016	20,749
Interest payments, 2017	2,625
Interest payments, 2018	0
Amortization expense, 2014	4,250
Amortization expense, 2015	8,500
Amortization expense, 2016	8,500
Amortization expense, 2017	2,125
Amortization expense, 2018	$0

Convertible_Notes_Details_Narr

Convertible Notes (Details Narrative) (USD $)	3 Months Ended		6 Months Ended			12 Months Ended	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Jun. 30, 2014
					Convertible Notes - Series B	Convertible Notes - Series B	Convertible Notes - Series C	Individual - Convertible Note
ConvertiblesNotesLineItems [Line Items]	'	'	'	'	'	'	'	'
Convertible notes, sold	'	'	'	'	'	$150,000	$95,000	$300,000
Convertible notes, payment terms	'	'	'	'	'	'Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month.	'Series C Notes bear interest at a rate of 12% per annum, payable to the holder at 1% per month, with principal amount due May 31, 2017..	'The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. The Company will also be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for 3 years until the note due date of February 27, 2017.
Convertible notes, price per share for conversion of shares of common stock	'	'	'	'	'	$0.10	$0.15	$0.15
Note holder additions	'	'	'	'	'	'	'	'The non-affiliate will receive 300,000 shares as part of the note agreement.
Additional paid in capital and discount	'	'	'	'	'	244,275	5,700	25,500
Amortization of debt discount	22,640	20,357	42,996	39,163	40,713	'	158	2,125
Convertible note, accrued interest	'	'	'	'	'	'	1,218	9,715
Private placement, 12% convertible notes (Series B Notes), principal amount	'	'	'	'	'	$1,865,000	'	'
Private placement, maturity date	'	'	'	'	'	31-Mar-16	31-May-17	27-Feb-17
Common stock issued	'	'	'	'	'	5,315,000	95,000	300,000

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Jun. 30, 2014	Jun. 30, 2010
Related Party Transactions [Roll Forward]	'	'	'
Shareholder note, beginning balance	$7,062	$0	'
Shareholder note, accrued interest	0	'	'
Shareholder note, payments	-7,062	'	'
Shareholder note, ending balance	0	'	42,944
Shareholder convertible note, beginning balance	10,936	'	'
Shareholder convertible note, accrued interest	48	'	'
Shareholder convertible note, foreign exchange gain	693	'	'
Shareholder convertible note, payments	-10,291	'	'
Shareholder convertible note, ending balance	$0	$0	'

Related_Party_Transactions_Det1

Related Party Transactions (Details Narrative) (USD $)	Dec. 31, 2013	Jun. 30, 2010
Related Party Transactions [Abstract]	'	'
Related party loan	$0	$42,944

Major_Customers_Details

Major Customers (Details) (USD $)

6 Months Ended

12 Months Ended

6 Months Ended

6 Months Ended

6 Months Ended

6 Months Ended

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Contract A

Contract A

Contract A

Contract E

Contract E

Contract E

Contract F

Contract F

Contract F

Contract H

Contract H

Contract H

Revenue, Major Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Major customer revenues

'

'

$529,754

$576,141

'

$455,253

$529,133

'

$279,189

$281,610

'

$149,839

$131,060

'

Major customer percent of revenue

44.00%

70.00%

21.00%

23.00%

'

18.00%

21.00%

'

11.00%

11.00%

'

6.00%

5.00%

'

Major customers accounts receivable closing balance

'

'

$18,485

'

$17,876

$106,730

'

$95,552

$50,883

'

$46,796

$24,843

'

$54,757

Major customers accounts receivable percentage

'

'

5.00%

'

6.00%

28.00%

'

34.00%

13.00%

'

17.00%

6.00%

'

19.00%

Major_Vendors_Details_Narrativ

Major Vendors (Details Narrative) (USD $)	3 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Major Vendors	'	'
Expenses for system software and support	$14,610	$13,811

Common_Stock_Transactions_Deta

Common Stock Transactions (Details Narrative) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Equity [Abstract]	'	'	'
Shares issued, convertible notes, shares	300,000	300,000	5,015,000
Shares issued, convertible notes, value	$25,500	$18,600	$225,675
Shares issued, Series C convertible notes, shares	95,000	'	'
Shares issued, Series C convertible notes, value	5,700	'	'
Shares issued for services, shares	5,000	'	'
Shares issued for services, value	$150	'	'

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	Jun. 30, 2014
Going Concern	'
Working capital deficit	$418,415

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative) (USD $)	12 Months Ended	1 Months Ended
	Dec. 31, 2012	Jul. 31, 2014	Jul. 31, 2014	Jul. 31, 2014	Jul. 31, 2014
		Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event
		Sublease Agreement	Capital Lease Agreement	Medical Equipment	Contingent Consideration
Subsequent Event [Line Items]	'	'	'	'	'
Refund of deposit	'	'	'	'	$20,000
Acquired medical equipment	'	'	'	'Subsequent to quarter end, the Company has completed the purchase of a CT and an x-ray machine for its SMI location. SMI has purchased a 16 Slice Toshiba Aquillion CT and a Viztek Digital Direct Radiography Straight Arm x-ray System. Both machines were delivered and installed prior to the end of July 2014. In addition SMI has completed building CT and Xray rooms prior to house the additional machines. Both new machines were put in operation at the end of July 2014.	'
Capital lease agreement	'On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI's obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.	'	'Subsequent to quarter end, the Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company's subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. The gross amount of the x-ray machine held under the capital lease is $78,500.	'	'
Sublease agreement	'	'Subsequent to quarter end, The Company's subsidiary, SMI, has entered into a sublease agreement for approximately one hundred fifty (150) square feet of space for the use of operating the x-ray machine as well as use of common areas of the sublessor. The lease calls for monthly payments of $2,000 beginning October 1, 2014.	'	'	'